NASDAQ OMX

Lantronix Launches Advanced Wireless Embedded IoT Gateways

Dela

-- Compact xPico® 200 Gateways Deliver Versatile Connectivity and Intelligent Networking --

IRVINE, Calif., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ:LTRX), a global provider of secure data access and management solutions for the industrial Internet of Things (IoT), today announced the launch of its xPico® 200 embedded IoT gateways. Measuring less than the size of a postage stamp, the compact xPico 200 embedded IoT gateways deliver robust Ethernet, Wi-Fi and Bluetooth connectivity, enterprise-grade security, and integrated manageability features that are ideal for industrial IoT applications.

A photo accompanying this announcement is available at 
http://www.globenewswire.com/NewsRoom/AttachmentNg/988d87cf-075e-4acf-90a1-27b42d595c46

"Today's advanced IoT applications require more than just simple connectivity," stated Shahram Mehraban, Lantronix vice president of marketing. "With the commercial launch of our xPico 200 product family, Lantronix is providing a robust compact solution that combines best-in-class wired and wireless connectivity, industrial grade design and intelligent networking that enables resource-constrained product development teams to reduce total cost of ownership and time to market for their industrial IoT solutions."

"With its state-of-the-art fast roaming capabilities and integrated manageability, the xPico 200 embedded gateways deliver reliable functionality and performance that will enable us to efficiently develop very cost competitive connected products," said Paul Blashewski, president of Prescient Wireless.

Combining the Lantronix intelligent networking communications engine with Cypress Semiconductor's industry-leading wireless SoC, the xPico 200 gateways deliver best-in-class managed industrial Wi-Fi connectivity that enables industrial OEMs to simplify and accelerate development of their smart connected solutions. Currently, the xPico 200 gateways are being designed into industrial, medical, retail, smart building and transportation verticals.

"Lantronix has developed an industry-leading secure embedded solution that enables OEMs to utilize the Cypress CYW43907 802.11n Wi-Fi MCU to provide network reliability and flexibility to do more," said Andrew Hunter, senior director of marketing at Cypress Semiconductor. "The xPico 200 series represents another milestone in our collaboration with Lantronix and addresses the growing need for industrial IoT solutions that deliver robust connectivity, processing capabilities and manageability."

The xPico 200 product family features include:

  • Highly integrated industrial grade Wi-Fi and versatile connectivity
    ° 
    Seamlessly integrated Wi-Fi, Ethernet and Bluetooth (BT and BLE) connectivity - no need to write complex drivers
    ° Dual-band 802.11a/b/g/n Wi-Fi delivers higher performance and reliability, minimizing interference
    ° Industrial grade design supporting long life and reliable operation in extreme environments
    ° Lantronix concurrent Soft AP + Client that provides device support and access without disrupting machine field operations
     
  • Robust data access and management
    ° 
    Intelligent networking and automatic connection management
    ° Field-tested TruPort® Serial and TruPort® Socket enable out-of-the-box connectivity locally and over the Internet for hundreds of serial machine protocols
    ° Built-in network communications engine simplifies embedded application development
    ° Pre-integrated with Lantronix MACH10(TM) IoT platform, including MACH10 Global Device Manager
     
  • Built-in comprehensive device security services
    ° 
    Enterprise-grade TruPort® Security ensure security of both data-at-rest and data-in-motion
    ° Secure connectivity to WPA2-Enterprise Wi-Fi networks
    ° Secure boot and secure FOTA (firmware over the air) features allow only authorized software to run on the gateway             

The xPico 240 is available through the worldwide network of authorized Lantronix distributors and resellers. xPico 250 evaluation kits will be available this month with product availability in early 2018. For more information about the xPico 200 product family, go to www.lantronix.com/xpico-200 or contact a local Lantronix sales office.

About Lantronix  
Lantronix, Inc. is a global provider of secure data access and management solutions for Internet of Things (IoT) assets. Our mission is to be the leading supplier of IoT solutions that enable companies to dramatically simplify the creation, deployment, and management of IoT projects while providing secure access to data for applications and people.

With more than two decades of experience in creating robust machine to machine (M2M) technologies, Lantronix is an innovator in enabling our customers to build new business models and realize the possibilities of the Internet of Things. Our connectivity solutions are deployed inside millions of machines serving a wide range of industries, including industrial, medical, security, transportation, retail, financial, environmental and government.

Lantronix is headquartered in Irvine, California. For more information, visit www.lantronix.com.

Learn more at the Lantronix blog, www.lantronix.com/blog, featuring industry discussion and updates. To follow Lantronix on Twitter, please visit www.twitter.com/Lantronix. View our video library on YouTube at www.youtube.com/user/LantronixInc or connect with us on LinkedIn at www.linkedin.com/company/lantronix.

Lantronix Media and Analyst Contact:  
E.E. Wang
Director, Corporate Marketing and Investor Relations
media@lantronix.com
investors@lantronix.com 
949-614-5879

Lantronix Sales: 
sales@lantronix.com
Americas +1 (800) 422-7055 (US and Canada) or +1 949-453-3990
Europe, Middle East and Africa +31 (0)76 52 36 744
Asia Pacific + 852 3428-2338
China + 86 21-6237-8868
Japan +81 (0) 50-1354-6201
India +91 994-551-2488

© 2017 Lantronix, Inc. All rights reserved. Lantronix, TruPort and xPico are registered trademarks, and MACH10 is a trademark, of Lantronix Inc. Wi-Fi is a registered trademark of Wi-Fi Alliance. The Bluetooth word mark and Bluetooth Smart Ready are registered trademarks owned by the Bluetooth SIG, Inc. Other trademarks and trade names are those of their respective owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Lantronix Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North24.9.2018 08:00Pressmeddelande

STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is issuing 6.8 million shares. The issue price of SEK 21 gives Asarina Pharma a pre money valuation of SEK 172 million. Conditioned that the over-allotment option of an additional 0.35 million shares is fully exercised, Asarina Pharma will be provided with a total of SEK 150.2 million before issue costs. Asarina Pharma is a Swedish biotech company focused on chronic diseases associated with the menstrual cycle. The portfolio company is developing the drug candidate sepranolone as a treatment for premenstrual dysphoric disorder (PMDD) and premenstrual migraine. A Phase IIb study is currently underway in PMDD with expected completion by the end of 2019. Furthermore, Asarina Pharma is planning a clinical Phase IIa study in menstrual migraine for the first half of 2019. Karolinska Development is a pas

Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet17.9.2018 08:00Pressmeddelande

Pressmeddelande 17 september 2018 Immunicum AB (publ) meddelar att Pawel Kalinski och Inge Marie Svane har valts in i det vetenskapliga rådet Immunicum AB (publ; IMMU.ST) meddelade i dag att två ledande immun-onkologiska experter har valts in i bolagets vetenskapliga råd för att fungera som strategiska resurser för Immunicum under bolagets fortsatta kliniska utveckling av sin ledande produkt, ilixadencel. Pawel Kalinski, MD, PhD, vice ordförande för translationell forskning vid den medicinska institutionen vid Roswell Park Comprehensive Cancer Center, och Inge Marie Svane, MD, PhD, professor, chef för det kliniska cancerforskningsprogrammet på medicinska fakulteten vid Köpenhamns universitet, chef för Center för cancerimmunterapi (CCIT) samt överläkare inom onkologi, Herlevs universitetssjukhus har valts in i rådet. - Vi är hedrade att ha experter med specialistkompetens inom området immunonkologi och cellterapi i vårt vetenskapliga råd, vilka kan erbjuda ytterligare vägledning när det

Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board17.9.2018 08:00Pressmeddelande

Press Release 17 September 2018 Immunicum AB (publ) Announces Appointment of Pawel Kalinski and Inge Marie Svane to Scientific Advisory Board Immunicum AB (publ; IMMU.ST) announced today the appointment of leading oncology experts to its Scientific Advisory Board with the addition of Pawel Kalinski, MD, PhD, Vice Chair for Translational Research within the Department of Medicine at Roswell Park Comprehensive Cancer Center, and Inge Marie Svane, MD, PhD, Professor, Head of the Clinical Cancer Research programme, Faculty of Health Sciences, University of Copenhagen, Director, Centre for Cancer Immunotherapy (CCIT), and consultant in Oncology, Herlev University Hospital. Both Scientific Advisory Board members will serve as a strategic resource to Immunicum as the company continues to advance the clinical development of its lead product, ilixadencel. "We are honored to have such highly specialized experts in the field of immuno-oncology and cell therapy join our Scientific Advisory Board a

Hoylu AB: HOYLU HIRES NEW CTO, SATOSHI NAKAJIMA AND ANNOUNCES EXPANSION INTO JAPAN14.9.2018 08:30Pressmeddelande

Malmo, Sweden, September 14, 2018 - Hoylu, a leading enterprise collaboration company, announced today Satoshi Nakajima will join Hoylu in the newly created position, as Chief Technology Officer and President of Hoylu Japan. Nakajima will guide the strategic technology direction and innovation of Hoylu while also leading the new Hoylu office in Tokyo, Japan. "Satoshi is a visionary and world-class technologist who has substantial experience in delivering world class innovations. He is joining the Company as we are extending our reach and expanding into Japan," said Stein Revelsby, CEO. "Satoshi's extensive experience in strategy and delivering technology that support a great user experience will make an immediate impact on the company." Nakajima will serve as President of Hoylu Japan and will report to Stein Revelsby. His leadership will strengthen customer relations and help develop new business among emerging and established Japanese companies while strengthening the global position

Hoylu AB: HOYLU ANSTÄLLER SATOSHI NAKAJIMA SOM NY CTO OCH EXPANDERAR TILL JAPAN14.9.2018 08:30Pressmeddelande

Malmö, Sverige, 14 september 2018 - Hoylu, ett ledande företag inom samarbetsmjukvara för företagsmarknaden annonserar idag att Satoshi Nakajima tar anställning som CTO (Chief Technology Officer) och President för Hoylu Japan. Nakajima kommer styra den strategiska inriktningen för företagets produkter och leda innovationsarbetet. Han kommer också leda Hoylus nyöppnade kontor i Tokyo, Japan. Satoshi är en visionär teknologiexpert som har stor erfarenhet av att skapa innovativa lösningar. Han kommer till Hoylu samtidigt som vi utökar marknaden till att även täcka in Japan säger Stein Revelsby, VD. "Satoshis långa och gedigna erfarenhet i strategiska frågor och tekniska lösningar med fokus på användarupplevelse kommer få stor betydelse för oss." Nakajima kommer även att bli President för Hoylu Japan och kommer rapportera till Stein Revelsby. Hans ledarskap kommer stärka existerande kundrelationer och utveckla nya affärer på den japanska marknaden och samtidigt bidra till att flytta fram p

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum